Original Article
J Korean Acad Nurs. 2013 Oct;43(5):636-648. Korean.
Published online Oct 31, 2013.  https://doi.org/10.4040/jkan.2013.43.5.636
© 2013 Korean Society of Nursing Science
Health-Illness Transition of Patients with Young-Onset Parkinson's Disease
Sung Reul Kim,1 and Sook Ja Lee2
1College of Nursing, Chonbuk National University, Jeonju, Korea.
2College of Nursing, Korea University, Seoul, Korea.

Address reprint requests to: Lee, Sook Ja. College of Nursing, Korea University, 126-1 Anam-dong 5ga, Sungbuk-gu, Seoul 136-705, Korea. Tel: +82-2-3290-4914, Fax: +82-2-927-4676, Email: scslee@korea.ac.kr
Received April 16, 2013; Accepted August 20, 2013.

 This article has been cited by 4 articles in  
 This article has been cited by Google Scholar.
 This article has been cited by 5 articles in  Scopus.
 This article has been cited by 3 articles in  Web of Science.


Abstract

Purpose

The purpose of this study was to explore the health-illness transition of patients with Young-Onset Parkinson's Disease (YOPD).

Methods

From June to November 2011, 17 patients with YOPD who visited a neurologic clinic in a tertiary hospital participated in the study. Data were collected through in-depth interviews and analyzed using the grounded theory of Strauss and Corbin.

Results

The core category of the participants' health-illness transition emerged as 'reshaping identity following uncontrollable changes'. The participants' health-illness transition process consisted of six phases in sequence: ego withdrawal, loss of role, frustration, change of thought, modification of life tract, and second life. Although most participants proceeded through the six phases chronologically, some returned to the frustration phase and then took up the remaining phases.

Conclusion

The study results provide an in-depth understanding of health-illness transition experiences in the participants. These findings suggest a need to develop appropriate nursing intervention strategies according to the different phases in the health-illness transition of patients with YOPD.
Keywords:
Parkinson disease; Qualitative research; Transition

Figures


 Figure 1
Health-illness transition process of patients with Young-Onset Parkinson's Disease: Reshaping identity following uncontrollable changes.
Click for larger image

Notes

This manuscript is based on a part of the first author's doctoral dissertation from Korea University.

References
1.
Burgener SC, Berger B. Measuring perceived stigma in persons with progressive neurological disease: Alzheimer's dementia and Parkinson's disease. Dementia 2008;7(1):31–53.
http://dx.doi.org/10.1177/1471301207085366.
2.
Calne SM, Kumar A. Young onset Parkinson's disease. Practical management of medical issues. Parkinsonism Relat Disord 2008;14(2):133–142.
http://dx.doi.org/10.1016/j.parkreldis.2007.07.007.
3.
Calne SM, Lidstone SC, Kumar A. Psychosocial issues in young-onset Parkinson's disease: Current research and challenges. Parkinsonism Relat Disord 2008;14(2):143–150.
http://dx.doi.org/10.1016/j.parkreldis.2007.07.012.
4.
Chick N, Meleis AI. Transitions: A nursing concern. In: Chinn P, editor. Nursing research methodology: Issues and implementation. Rockville, MD: Aspen Publishers; 1986. pp. 237-257.
5.
Chung SJ. Genetics in Parkinson' disease. J Korean Med Assoc 2011;54(1):70–78.
http://dx.doi.org/10.5124/jkma.2011.54.1.70.
6.
de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5(6):525–535.
http://dx.doi.org/10.1016/s1474-4422(06)70471-9.
7.
Ellis JM. Psychological transition into a residential care facility: Older people's experiences. J Adv Nurs 2010;66(5):1159–1168.
http://dx.doi.org/10.1111/j.1365-2648.2010.05280.x.
8.
Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M, et al. The movement disorder society evidence-based medicine review update: Treatments for the motor symptoms of Parkinson's disease. Mov Disord 2011;26 Suppl 3:S2–S41.
http://dx.doi.org/10.1002/mds.23829.
9.
Fox SH, Lang AE. Levodopa-related motor complicationsphenomenology. Mov Disord 2008;23 Suppl 3:S509–S514.
http://dx.doi.org/10.1002/mds.22021.
10.
Guba EG, Lincoln YS. In: Effective evaluation: Improving the usefulness of evaluation results through responsive and naturalistic approaches. San Francisco, CA: Jossey-Bass; 1981.
11.
Haahr A, Kirkevold M, Hall EO, Østergaard K. Living with advanced Parkinson's disease: A constant struggle with unpredictability. J Adv Nurs 2011;67(2):408–417.
http://dx.doi.org/10.1111/j.1365-2648.2010.05459.x.
12.
Kim SR, Chung SJ, Hee SY, Im JH, Lee MC. Factors related to quality of life in patients with Parkinson's disease. J Korean Neurol Assoc 2005;23(6):770–775.
13.
Kostić VS. Treatment of young-onset Parkinson's disease: Role of dopamine receptor agonists. Parkinsonism Relat Disord 2009;15 Suppl 4:S71–S75.
http://dx.doi.org/10.1016/s1353-8020(09)70839-9.
14.
Kralik D, Visentin K, van Loon A. Transition: A literature review. J Adv Nurs 2006;55(3):320–329.
http://dx.doi.org/10.1111/j.1365-2648.2006.03899.x.
15.
Lee KO, Lyoo CH, Lee MS. Parkin gene mutation in Korean patients with young age onset sporadic Parkinson's disease. J Korean Neurol Assoc 2006;24(1):26–30.
16.
Meleis AI, Sawyer LM, Im EO, Messias DK, Schumacher K. Experiencing transitions: An emerging middle-range theory. ANS Adv Nurs Sci 2000;23(1):12–28.
17.
National Health Insurance Service. 2002-2008 medical treatment trends analysis of geriatric diseases in Korea. 2010 [Retrieved February 1, 2010].
from http://www.nhic.or.kr/cms/board/board/Board.jsp?act=VIEW&communityKey=B0039&boardId=21956.
18.
Park YR. Process of seeking positive life of patients with Parkinson' s disease. J Korean Acad Nurs 2006;36(5):710–720.
19.
Periquet M, Latouche M, Lohmann E, Rawal N, De Michele G, Ricard S, et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 2003;126(Pt 6):1271–1278.
20.
Schrag A, Ben-Shlomo Y, Quinn NP. Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ 2000;321(7252):21–22.
21.
Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Young-versus older-onset Parkinson's disease: Impact of disease and psychosocial consequences. Mov Disord 2003;18(11):1250–1256.
http://dx.doi.org/10.1002/mds.10527.
22.
Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol 2006;5(4):355–363.
http://dx.doi.org/10.1016/s1474-4422(06)70411-2.
23.
Stocchi F, Tagliati M, Olanow CW. Treatment of levodopa-induced motor complications. Mov Disord 2008;23 Suppl 3:S599–S612.
http://dx.doi.org/10.1002/mds.22052.
24.
Strauss A, Corbin JM. In: Basics of qualitative research: Techniques and procedures for developing grounded theory. 2nd ed. Thousand Oaks, CA: Sage Publications, Inc; 1998.
25.
Whitney CM. Maintaining the square. How older adults with Parkinson's disease sustain quality in their lives. J Gerontol Nurs 2004;30(1):28–35.
26.
Williams S, Keady J. 'stony road… 19 year journey' ridging' hrough late-stage Parkinson' disease. J Res Nurs 2008;13(5):373–388.
http://dx.doi.org/10.1177/1744987108095160.